TIGERTRIEVER
Commercial- Indications
- Ischemic stroke
Company intelligence / Profile preview
Rapid Medical develops and markets proprietary, responsive, remotely adjustable neurovascular interventional devices for the treatment of ischemic and hemorrhagic strokes. Their products are engineered to allow individualized, real-time adaptation during procedures, with over 75 clinical publications supporting their use[1][4]. The company’s Tigertriever device is being studied for cognitive benefits in ischemic stroke patients[5].
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rapid Medical.